Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment. - Cabrera-Rode, Eduardo; Perich, Pedro; Diaz-Horta, Oscar; Tiberti, Claudio; Molina, Gisela; Arranz, Celeste; Martin, Juana M.; Licea, Manuel; De Leiva, Alberto; Puig-Domingo, Manuel; Dimario, Umberto (Autoimmunity, 2002)